Prev：Reprogramming of glycometabolism caused by low-level lead in vascular smooth muscle cells(ABP0114-3)
Next：Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis(A21020-7.7)
